[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100622425":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":20,"responsibleParty":31,"collaborators":35,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":20,"eligibilityCriteria":45,"healthyVolunteers":46,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":20,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":62,"overallStatus":68,"whyStopped":20,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":20},{"fullName":5,"class":6},"Chung Shan Medical University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"LDCT screening arm","EXPERIMENTAL","LDCT screening, lung function test, and specimens collections",[13],"Diagnostic Test: Low dose computed tomography",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DIAGNOSTIC_TEST","Low dose computed tomography","Low dose computed tomography for lung cancer screening",[9],null,[22,28],{"name":23,"role":24,"phone":25,"phoneExt":26,"email":27},"Gee-Chen Chang, MD, PhD.","CONTACT","886-4-24739595","34414","geechen@gmail.com",{"name":29,"role":24,"phone":25,"phoneExt":26,"email":30},"Lung-Ying Huang, Mrs.","cshe1365@csh.org.tw",{"type":32,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Gee-Chen Chang","Professor",[36],{"name":37,"class":38},"Ministry of Health and Welfare, Taiwan","OTHER_GOV","100622425","lung-cancer-screening-in-population-who-had-never-smoked-100622425",false,"NCT07383454","Lung Cancer Screening in Population Who Had Never Smoked","Lung Cancer Screening in Population Who Had Never Smoked and the Validation of Lung Cancer Risk Prediction Model","Inclusion Criteria:\n\n1. Individuals with no history of smoking.\n2. Aged 40 to 80 years.\n3. Willing to provide written informed consent and complete questionnaire assessments.\n4. After undergoing examinations, willing to provide relevant biological information, including but not limited to: blood samples, urine samples, pulmonary function test results, imaging data, and tissue specimens obtained from invasive biopsies or surgical procedures (if applicable).\n\nExclusion Criteria:\n\n1. History of lung cancer, or a diagnosis of any malignancy other than skin cancer or cervical carcinoma in situ within the past five years.\n2. Undergoing chest computed tomography (CT) scans within the past 18 months.\n3. Unexplained hemoptysis within the past one month.\n4. Unexplained weight loss exceeding 6 kilograms within the past one year.\n5. Pregnancy.",true,"ALL","40 Years","80 Years",{"count":51,"type":52},2500,"ESTIMATED","INTERVENTIONAL",[55],"NA","Study design: prospective, single arm.\n\nObjectives: survey lung cancer detection rate of low-dose computed tomography (LDCT) screening in individuals who had never smoked.\n\nParticipants will undergo questionnaires, and collecting specimens including blood, urine, and medical informations including results of pulmonary function tests, and LDCT screening upon inclusion. The participants will be followed up according to current standards of clinical practice.",[58,59,60,61],"Lung Cancer (Diagnosis)","Non-Small Cell Lung Cancer","Small Cell Carcinoma of Lung","Screening Strategy",[63,64,65,66,67],"Low dose computed tomography (LDCT)","Lung cancer in individuals who had never smoked (LCINS)","Lung cancer risk prediction model (LCRPM)","Lung cancer","Non-small cell lung cancer (NSCLC)","NOT_YET_RECRUITING","2026-01-26",{"date":71,"type":72},"2026-02-03","ACTUAL",{"date":74,"type":52},"2026-02-01",{"date":76,"type":52},"2034-12",{"name":5,"class":6}]